0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

From the JAMA Network | 
Mark Olfson, MD, MPH
JAMA. 2015;313(12):1256-1257. doi:10.1001/jama.2014.15743.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2015;313(12):1199. doi:10.1001/jama.2015.2195.

The JAMA Forum |  FREE
Austin B. Frakt, PhD
JAMA. 2015;313(11):1091-1092. doi:10.1001/jama.2015.0544.

Original Investigation | 
Hongmei Nan, MD, PhD; Carolyn M. Hutter, MS, PhD; Yi Lin, MS; et al.
JAMA. 2015;313(11):1133-1142. doi:10.1001/jama.2015.1815.
Includes: Supplemental Content

Global Health | 
M. J. Friedrich
JAMA. 2015;313(11):1093. doi:10.1001/jama.2015.1096.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;313(10):1052-1053. doi:10.1001/jama.2015.1302.

Viewpoint | 
J. Robert Powell, PharmD
JAMA. 2015;313(10):1013-1014. doi:10.1001/jama.2015.59.

Viewpoint | 
Om P. Ganda, MD
JAMA. 2015;313(10):1009-1010. doi:10.1001/jama.2015.216.

Viewpoint | 
Connie B. Newman, MD; Jonathan A. Tobert, MD, PhD
JAMA. 2015;313(10):1011-1012. doi:10.1001/jama.2015.1335.

Original Investigation | 
Axel Maurice-Szamburski, MD; Pascal Auquier, MD, PhD; Véronique Viarre-Oreal, PhD; et al.
JAMA. 2015;313(9):916-925. doi:10.1001/jama.2015.1108.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia:  A Randomized Clinical Trial
Joris Berwaerts, MD; Yanning Liu, MS; Srihari Gopal, MD, MHS; et al.
JAMA Oncology
Editorial  | 
Thiopurines for the Treatment of Acute Lymphoblastic Leukemia in Children:  What’s Old Is New
Franklin O. Smith, MD; Maureen M. O’Brien, MD, MS
JAMA Oncology
Original Investigation  | 
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia:  A Children’s Oncology Group Study
Smita Bhatia, MD, MPH; Wendy Landier, PhD, RN; Lindsey Hageman, MPH; et al.
JAMA Oncology
Viewpoint  | 
The Cost and Value of Anti–Epidermal Growth Factor Receptor Therapies:  Let's Not Be Rash
Leonard B. Saltz, MD